We have located links that may give you full text access.
Implementation of an Enhanced Recovery After Surgery Program for Colorectal Surgery at a Community Teaching Hospital.
INTRODUCTION: Perioperative programs aimed at decreasing surgical stress to colorectal patients can reduce hospital length of stay and morbidity while improving the patient’s perception of the surgical experience. Our goal was to transform patient care from a perioperative platform based on individual physician and nurse choice to a standardized evidence-based Enhanced Recovery After Surgery (ERAS) protocol for all patients undergoing elective colorectal resections.
METHODS: An institutional review board-approved retrospective review was performed for the first 12 months of ERAS protocol-driven patient care in 2014 and compared to the prior 12 months (2013) of individual choice managed care.
RESULTS: Ninety-nine patients and 92 patients underwent elective colorectal surgery in the post- ERAS and pre-ERAS period, respectively. The post-ERAS group experienced a shorter length of stay (4.9±2.7 vs 6.2±4.0 days, P=0.001), were more likely to advance to a general diet on postoperative day 1 (72% vs 9%, P<0.001), and had quicker return of bowel function (2.3±1.8 vs 2.8±1.1 days, P<0.0001) compared to the pre-ERAS group. Thirty-day complications were similar between the post-ERAS and pre-ERAS groups and included anastomotic leak (4% vs 0%, P=0.120), surgical site infections (4% vs 8%, P=0.990), and abscess (3% vs 3%, P=0.990). Eleven (11%) post-ERAS patients and 7 (8%) pre-ERAS patients were readmitted within 30 days postoperative (P=0.410).
CONCLUSION: We implemented change through a new system of care based upon standardized evidence-based ERAS protocols through the preoperative, intraoperative, and postoperative patient experience. In the first year of the ERAS program, patients experienced a reduced length of stay without a significant difference in morbidity or mortality.
METHODS: An institutional review board-approved retrospective review was performed for the first 12 months of ERAS protocol-driven patient care in 2014 and compared to the prior 12 months (2013) of individual choice managed care.
RESULTS: Ninety-nine patients and 92 patients underwent elective colorectal surgery in the post- ERAS and pre-ERAS period, respectively. The post-ERAS group experienced a shorter length of stay (4.9±2.7 vs 6.2±4.0 days, P=0.001), were more likely to advance to a general diet on postoperative day 1 (72% vs 9%, P<0.001), and had quicker return of bowel function (2.3±1.8 vs 2.8±1.1 days, P<0.0001) compared to the pre-ERAS group. Thirty-day complications were similar between the post-ERAS and pre-ERAS groups and included anastomotic leak (4% vs 0%, P=0.120), surgical site infections (4% vs 8%, P=0.990), and abscess (3% vs 3%, P=0.990). Eleven (11%) post-ERAS patients and 7 (8%) pre-ERAS patients were readmitted within 30 days postoperative (P=0.410).
CONCLUSION: We implemented change through a new system of care based upon standardized evidence-based ERAS protocols through the preoperative, intraoperative, and postoperative patient experience. In the first year of the ERAS program, patients experienced a reduced length of stay without a significant difference in morbidity or mortality.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app